Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSulNOx Regulatory News (SNOX.PL)

Share Price Information for SulNOx (SNOX.PL)

Share Price is delayed by 15 minutes
Get Live Data
52.50    0.00 (0.00%)
Bid:
50.00
Ask:
55.00
Spread: 5.00 (10.00%)
Market Cap: £75.89m
SNOX.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday SulNOx Share Chart

Subscription for New Shares

3 Dec 2024 07:00

RNS Number : 5114O
SulNOx Group PLC
03 December 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

 3 December 2024

 

SulNOx Group Plc (the "Company" or "SulNOx")

 

Subscription for New Shares

Exercise of Warrants

Holdings in the Company

Total Voting Rights

(Aquis Stock Exchange: SNOX)

 

Subscription for New Shares and Exercise of Warrants

 

The board of directors of the Company (the "Board") is pleased to announce that it has raised a total, before expenses, of £1,875,000 from a group of investors, consisting of both new and existing shareholders, including a strategic investor (the "Investors") and an existing warrant holder.

 

The Investors have agreed to subscribe for a total of 3,302,076 new ordinary shares of 2 pence each ("Ordinary Shares") at a price of 46.6 pence per Ordinary Share (representing a discount of 11.5% to the average closing price of the Ordinary Shares for the 5 trading days up to and including 29 November of 52.7p) raising £1,538,768 (the "Subscription").

 

Under the Subscription, the Investors will also receive warrants to subscribe for further Ordinary Shares at a price of 58.8 pence per Ordinary Share (the "Warrants"). The Investors will receive 1 Warrant for every 2.5 new Ordinary Shares subscribed. A total of 1,320,829 Warrants will be issued. The Board will seek new allotment authorities relating to the Warrants at the Company's 2025 annual general meeting, with the Warrant holders having 3 years from the date that the new authorities are granted to exercise the Warrants. Should new allotment authorities not be granted at the Company's 2025 annual general meeting, such authorities will be sought at the 2026 and 2027 meetings.

 

The Company is pleased to announce that a wholly owned subsidiary of McQuilling Partners, Inc. ("McQuilling") has invested in the Company and will be the preferred partner of the Company to promote and sell the SulNOx products in the U.S. market. McQuilling is a privately-owned marine services company formed in 1972 and headquartered in New York with offices in Singapore, Athens, Madrid, Dubai, Houston, Lima, Mexico City, Rio de Janeiro and Mumbai. McQuilling and its affiliated companies have 180 employees serving clients in the shipping, commodity, renewable and financial services industries covering brokerage, operations and administration, research, data services and consulting.

 

In addition, one of the subscribers, an institutional investor who participated in the fundraising announced on 22 December 2023, has indicated an intention to exercise 1,159,420 warrants at an exercise price of 29 pence per Ordinary Share, raising a further £336,232 (the "Exercise").

 

The proceeds from the Subscription and the Exercise will be utilised for the working capital requirements of the Company. In particular, the Company intends to increase its global stock locations, and therefore stock inventory levels, of the SulNOxEcoTM fuel conditioner in expectation of a material increase of marine sales during 2025 resulting from positive evaluations, as highlighted in the Trading Update (6 November 2024) and Final Results (9 September 2024) announcements.

 

Among the investors under the Subscription are two existing substantial shareholders of the Company, Constantine Logothetis and Nistadgruppen AS ("Nistad"). Mr Logothetis has subscribed for 1,703,365 new Ordinary Shares (via Arrowcove Ltd, a company he controls) and Nistad for 472,103 new Ordinary Shares. As Mr Logothetis and Nistad each have an existing interest in more than 10% of the Company's Ordinary Shares, their subscriptions constitute related party transactions under the AQSE Growth Market Apex Rules. The Board has concluded, having exercised reasonable care, skill and diligence, that their Subscriptions are fair and reasonable as far as the shareholders of the Company are concerned.

 

The new Ordinary Shares for both the Subscription and the Exercise will be allotted under the Company's existing unspent share issue authorities and are expected to be admitted to trading on the AQSE Growth Market on 13 December 2024 ("Admission"). 

 

Radu Florescu, Chairman of SulNOx, commented, "We are delighted to again receive significant further support from our two largest shareholders, Mr Logothetis and Nistadgruppen AS, and to welcome McQuilling Partners as an important new investor and strategic partner for the U.S. market. McQuilling has highly relevant expertise and networks, not only in the marine sector, where SulNOx has seen encouraging success, but also in key industries facing decarbonisation challenges."

 

"This new commitment of funds reflects the strong news flow from SulNOx during this year, regarding additional industries, geographies, distributors, new orders, and a rapidly growing patent portfolio."

 

John M. Schmidt, CEO of McQuilling, commented, "We are excited to have concluded this investment in SulNOx and to actively engage in growing the business particularly in the U.S. market. SulNOx has developed an impressive product that reduces liquid hydrocarbon fuel consumption, associated greenhouse gases and harmful particulate matter emissions. We look forward to extending our partnership and offering these very compelling benefits to industry."

 

Holdings in the Company

 

Following Admission, the percentage of Ordinary Shares held by significant shareholders will be, to the best of the knowledge of the Company, as follows:

 

Shareholder

Current Ordinary Shares Held

% of Current Ordinary Shares Held

Ordinary Shares Held on Admission

% of Ordinary Shares Held on Admission

 

Constantine Logothetis *

30,485,307

25.09%

32,771,264

26.01%

Nistadgruppen AS

17,611,111

14.49%

18,083,214

14.35%

James Redman Jr.

8,659,200

7.12%

8,659,200

6.87%

Richard Leggatt

6,807,500

5.60%

6,807,500

5.40%

Unicorn Asset Management

6,536,565

5.38%

6,536,565

5.19%

Angela Bravo **

5,719,010

4.71%

5,719,010

4.54%

 

* This includes shares held by Tergeo Ltd, Arrowcove Ltd and Kambos SA in which Constantine Logothetis holds a majority interest.

 

** This includes shares owned by Sungold Escrow Nominees Ltd, a company controlled by Ms Bravo, and by trusts for the benefit of Ms Bravo's immediate family. Ms Bravo's previously reported holding included voting rights for but not beneficial ownership of 2,298,810 Ordinary Shares. The current holding includes 3,420,200 with both voting rights and beneficial ownership of Ordinary Shares and 2,298,810 with just voting rights.

 

Total Voting Rights

 

On Admission, the Company will have 126,012,442 Ordinary Shares in issue, each with one voting right. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company is 126,012,442. This figure should be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

- Ends -

 

For further information please contact:

 

SulNOx Group plc Steven Cowin, CFO

 

Tel: 07624 491 821

Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale

Tel: 020 3328 5656

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFFFEFFFLFIIS
Date   Source Headline
3rd Jun 202612:00 pmRNSGrant of Share Options
1st Jun 20267:00 amRNS-RDistribution agreement with France's DLBC
26th May 20267:00 amRNS-RSkyzone deal marks entry into Pakistan market
11th May 20267:00 amRNSPPS Deal Expands India & Sri Lanka Distribution
7th May 20267:00 amRNSAlgeria patent granted for fuel oil reclamation
5th May 20267:00 amRNSDistribution agreement with India's Aditya
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNS-RInvestor Webinar via Turner Pope Investments
29th Apr 20267:00 amRNSTrading Update: Record revenues in Q4 & Full Year
24th Apr 20267:00 amRNSIssue of Shares to EPS Ventures & Consultant
22nd Apr 20267:00 amRNSHong Kong patent granted for fuel oil reclamation
15th Apr 20267:00 amRNSSubscription for Shares to raise £2m
25th Mar 20267:00 amRNSPatents for Chile, Peru, Israel
16th Mar 20267:00 amRNS-RIndependent testing demonstrates biofuel benefits
16th Mar 20267:00 amRNS-RIndependent testing demonstrates biofuel benefits
5th Mar 20267:00 amRNSPan Marine distribution and fleet adoption
25th Feb 20267:00 amRNS-RDistribution agreement with Fluid Intelligence Oy
10th Feb 20267:00 amRNS-RDistribution agreement with Motor Plus, Panama
2nd Feb 20265:00 pmRNSQ3 Trading Update: Year-to-date sales up 161%
30th Jan 20265:00 pmRNSTotal Voting Rights
27th Jan 20267:00 amRNSSouth Korea patent strengthens Asia presence
23rd Jan 20267:00 amRNSIssue of Shares to EPS Ventures Pte Ltd.
19th Jan 20267:00 amRNSSth Africa patent expands fuel oil reclamation IP
16th Jan 20267:00 amRNSAsia presence strengthened with Vietnam patent
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSFinancial Results for the 6 Months to 30 Sep 2025
29th Dec 20257:00 amRNSFinancial Results for the 6 Months to 30 Sep 2025
22nd Dec 20257:00 amRNSExercise of Warrants
22nd Dec 20257:00 amRNSExercise of Warrants
16th Dec 20257:00 amRNSAustralia patent granted
15th Dec 202512:00 pmRNSGrant of Share Options
4th Dec 20257:00 amRNSIssue of Warrants
24th Nov 20257:00 amRNSMajor distribution agreement with Drew Marine
11th Nov 20257:00 amRNS-RSulnox at Aquis Showcase Investor Conference
6th Nov 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
3rd Nov 20257:00 amRNSSpring Marine fleet-wide adoption on 28 vessels
31st Oct 20255:00 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSQ2 Trading Update: Another Record Quarter
23rd Oct 20257:30 amRNSIssue of Shares to EPS Ventures Pte Ltd.
23rd Oct 20257:00 amRNSEurope patent granted for fuel reclamation
16th Oct 20257:00 amRNS-RSulnox selected for ADIPEC 2025
14th Oct 20252:30 pmRNS-RSulnox to present at Global Markets Forum New York
30th Sep 20255:00 pmRNSTotal Voting Rights
26th Sep 20255:32 pmRNSResult of AGM
22nd Sep 20259:00 amRNSIssue of Shares to Consultant
8th Sep 20257:00 amRNS-RSulnox Expands UK Marine Market Access with C-Quip
5th Sep 20256:00 pmRNSAnnual Financial Report
5th Sep 20251:00 pmRNSFinal Results & Trading Update
3rd Sep 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.